CSB 2.84 Addition of Alfaxalone to schedule IV. Section 961.20 (2) (a), Stats., is renumbered 961.20 (2) (af), Stats.
961.20 (2) (ab) Alfaxalone
The Affirmative Action order, dated July 9, 2021, took effect on July 19, 2021 to allow for publication in the Administrative Register and expires upon promulgation of a final rule.
Summary of, and comparison with, existing or proposed federal regulation:
On February 27, 2014, the Department of Justice, Drug Enforcement Administration published its final rule in the Federal Register listing Alfaxalone into schedule IV of the federal Controlled Substances Act. The scheduling action is effective March 31, 2014.
Summary of public comments received on statement of scope and a description of how and to what extent those comments and feedback were taken into account in drafting the proposed rule: N/A
Comparison with rules in adjacent states:
Illinois: Illinois has not scheduled Alfaxalone as a controlled substance.
Iowa: Iowa has listed Alfaxalone as a schedule IV controlled substance [Iowa Administrative Code s. 124.210 (3) (bb)]. Michigan: Michigan has not scheduled Alfaxalone as a controlled substance.
Minnesota: Minnesota has listed Alfaxalone as a schedule IV controlled substance [Minnesota State Statutes s. 152.02 (5) (c) (1)]. Summary of factual data and analytical methodologies:
The methodology was to schedule Alfaxalone to conform with the federal Controlled Substances Act.
Analysis and supporting documents used to determine effect on small business or in preparation of economic impact report:
The proposed rules were posted for a period of 14 days to solicit public comment on economic impact, including how the proposed rules may affect businesses, local government units, and individuals. No comments were received.
Fiscal Estimate and Economic Impact Analysis:
The Fiscal Estimate and Economic Impact Analysis is attached.
Effect on small business:
These proposed rules do not have an economic impact on small businesses, as defined in s. 227.114 (1), Stats. The Department’s Regulatory Review Coordinator may be contacted by email at Jennifer.Garrett@wisconsin.gov, or by calling (608) 266-6795. Agency contact person:
Nilajah Hardin, Administrative Rules Coordinator, Department of Safety and Professional Services, Division of Policy Development, 4822 Madison Yards Way, P.O. Box 8366, Madison, Wisconsin 53708; telephone 608-267-7139; email at DSPSAdminRules@wisconsin.gov. ------------------------------------------------------------------------------------------------------------
TEXT OF RULE
Section 1. CSB 2.84 is created to read:
CSB 2.84 Addition of Alfaxalone to schedule IV. Section 961.20 (2) (a), Stats., is renumbered to 961.20 (2) (af), Stats.
961.20 (2) (ab) Alfaxalone.
Section 2. EFFECTIVE DATE. The rules adopted in this order shall take effect on the first day of the month following publication in the Wisconsin Administrative Register, pursuant to s. 227.22 (2) (intro.), Stats. ------------------------------------------------------------------------------------------------------------
(END OF TEXT OF RULE)
------------------------------------------------------------------------------------------------------------
Dated _________________ Agency __________________________________
Chairperson
Controlled Substances Board
